These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8410523)

  • 1. Persistent hyperinsulinemic hypoglycemia of infancy: long-term octreotide treatment without pancreatectomy.
    Glaser B; Hirsch HJ; Landau H
    J Pediatr; 1993 Oct; 123(4):644-50. PubMed ID: 8410523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The enigma of persistent hyperinsulinemic hypoglycemia of infancy.
    Daneman D; Ehrlich RM
    J Pediatr; 1993 Oct; 123(4):573-5. PubMed ID: 8410509
    [No Abstract]   [Full Text] [Related]  

  • 3. Preoperative use of octreotide in a newborn with persistent hyperinsulinemic hypoglycemia of infancy.
    Apak RA; Yurdakök M; Oran O; Senocak ME; Cağlar M
    J Pediatr Endocrinol Metab; 1998 Mar; 11 Suppl 1():143-5. PubMed ID: 9642652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short- and long-term use of octreotide in the treatment of congenital hyperinsulinism.
    Thornton PS; Alter CA; Katz LE; Baker L; Stanley CA
    J Pediatr; 1993 Oct; 123(4):637-43. PubMed ID: 8410522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal growth after administration of octreotide: report on a case of persistent hyperinsulinemic hypoglycemia of infancy treated by continuous subcutaneous injection of octreotide.
    Kuno T; Fujita I; Ohta M; Kanemitsu H; Miyazaki S; Miyamoto S
    Endocr J; 1999 Mar; 46 Suppl():S47-9. PubMed ID: 12054118
    [No Abstract]   [Full Text] [Related]  

  • 6. Persistent hyperinsulinemic hypoglycemia of infancy: long-term results.
    Dacou-Voutetakis C; Psychou F; Maniati-Christidis M
    J Pediatr Endocrinol Metab; 1998 Mar; 11 Suppl 1():131-41. PubMed ID: 9642651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term non-surgical therapy of severe persistent congenital hyperinsulinism with glucagon.
    Mohnike K; Blankenstein O; Pfuetzner A; Pötzsch S; Schober E; Steiner S; Hardy OT; Grimberg A; van Waarde WM
    Horm Res; 2008; 70(1):59-64. PubMed ID: 18493152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is 95% pancreatectomy the procedure of choice for treatment of persistent hyperinsulinemic hypoglycemia of the neonate?
    Shilyansky J; Fisher S; Cutz E; Perlman K; Filler RM
    J Pediatr Surg; 1997 Feb; 32(2):342-6. PubMed ID: 9044150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linear growth during long-term treatment with somatostatin analog (SMS 201-995) for persistent hyperinsulinemic hypoglycemia of infancy.
    DeClue TJ; Malone JI; Bercu BB
    J Pediatr; 1990 May; 116(5):747-50. PubMed ID: 2184212
    [No Abstract]   [Full Text] [Related]  

  • 10. Hyperinsulinemic hypoglycemia of infancy (nesidioblastosis) in clinical remission: high incidence of diabetes mellitus and persistent beta-cell dysfunction at long-term follow-up.
    Leibowitz G; Glaser B; Higazi AA; Salameh M; Cerasi E; Landau H
    J Clin Endocrinol Metab; 1995 Feb; 80(2):386-92. PubMed ID: 7852494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combination of nifedipine and octreotide treatment in an hyperinsulinemic hypoglycemic infant.
    Durmaz E; Flanagan SE; Parlak M; Ellard S; Akcurin S; Bircan I
    J Clin Res Pediatr Endocrinol; 2014; 6(2):119-21. PubMed ID: 24932607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term treatment with the somatostatin analogue SMS 201-995: alternative to pancreatectomy in persistent hyperinsulinaemic hypoglycaemia of infancy.
    Glaser B; Landaw H
    Digestion; 1990; 45 Suppl 1():27-35. PubMed ID: 2185966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical use of the long acting somatostatin analogue octreotide in pediatrics.
    Tauber MT; Harris AG; Rochiccioli P
    Eur J Pediatr; 1994 May; 153(5):304-10. PubMed ID: 8033916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy for persistent hyperinsulinemic hypoglycemia of infancy. Understanding the responsiveness of beta cells to diazoxide and somatostatin.
    Kane C; Lindley KJ; Johnson PR; James RF; Milla PJ; Aynsley-Green A; Dunne MJ
    J Clin Invest; 1997 Oct; 100(7):1888-93. PubMed ID: 9312191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Octreotide in hyperinsulinism.
    Barrons RW
    Ann Pharmacother; 1997 Feb; 31(2):239-41. PubMed ID: 9034427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment with diazoxide in childhood hyperinsulinism.
    Grant DB; Dunger DB; Burns EC
    Acta Endocrinol Suppl (Copenh); 1986; 279():340-5. PubMed ID: 3465173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten years' experience of persistent hyperinsulinaemic hypoglycaemia of infancy.
    Tyrrell VJ; Ambler GR; Yeow WH; Cowell CT; Silink M
    J Paediatr Child Health; 2001 Oct; 37(5):483-8. PubMed ID: 11885714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperinsulinism in infants and children.
    Stanley CA
    Pediatr Clin North Am; 1997 Apr; 44(2):363-74. PubMed ID: 9130925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of 114 patients with congenital hyperinsulinism.
    Meissner T; Wendel U; Burgard P; Schaetzle S; Mayatepek E
    Eur J Endocrinol; 2003 Jul; 149(1):43-51. PubMed ID: 12824865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of diabetes following pancreatic surgery in patients with congenital hyperinsulinism.
    Welters A; Meissner T; Grulich-Henn J; Fröhlich-Reiterer E; Warncke K; Mohnike K; Blankenstein O; Menzel U; Datz N; Bollow E; Holl RW
    Orphanet J Rare Dis; 2018 Dec; 13(1):230. PubMed ID: 30577875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.